Teladoc CEO Jason Gorevic to leave the company

In a decision that surprised Wall Street analysts, Teladoc Health announced that long-time CEO Jason Gorevic will depart the company immediately.

In a statement, the board of directors said, CFO Mala Murthy will take over as the acting chief executive.

The leadership change comes as the virtual care company hunts for a path forward after a period of explosive growth during the Covid-19 pandemic. In February the company projected it would see single-digital growth for the next several years. Teladoc shares are down from its 2021 high of around $294, with the stock currently trading at around $14 a share.

Get unlimited access to award-winning journalism and exclusive events.

Smoking impairs immune response, even after quitting, new study says

Public health messages have told us for decades that if you smoke, you should quit. And if you don’t smoke, don’t start. But a new

February 14, 2024

Antibody fragment discovery could lead to much-needed treatment for light chain amyloidosis

In people with a rare condition called light chain amyloidosis, light chain proteins-;which are a component of antibodies-;mutate and build up in different organs.

July 10, 2024

New imaging tool analyzes extracellular vesicles to track cancer progression

A University of Rochester research team is reporting a new way to detect cancer cells with a “liquid biopsy” that’s designed to be simpler, faster,

November 4, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.